《大行報告》美銀證券調整耐世特(01316.HK)盈測 維持「買入」看16元
美銀證券發表研究報告指,耐世特(01316.HK)上半年表現勝預期,收入增43%,主因去年低基數、穩健的汽車產量復甦、美元貶值等所致。剔除一次性項目後,收入增38%,毛利率13.1%,按年增3個百分點,但較去年下半年低2.8個百分點,主因受原材料成本及供應鏈和物流影響。
該行指,上半年新訂單13億美元,增長較慢,整體在手訂單245億美元,公司維持全年新訂單目標在64億美元。計入上半年業績後,下調公司今年盈利預期2%,以反映下半年不確定性增加,如原材料價格和物流成本,但上調2022至23年盈利預測2%及4%,目標價維持在16元,重申「買入」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.